Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
about
Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen productionHistone deacetylase: a potential therapeutic target for fibrotic disordersAngiogenesis inhibitors in the treatment of cancer.Enhanced histone deacetylase enzyme activity in primary myelofibrosis.
P2860
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@ast
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@en
type
label
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@ast
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@en
prefLabel
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@ast
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@en
P2860
P1433
P1476
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
@en
P2093
Brijesh Arora
Ruben Mesa
P2860
P304
P356
10.1080/10428190400003267
P577
2004-12-01T00:00:00Z